IBM, Rice University partner on robot that will take care of the elderly

IBM is working with Houston-based Rice University to create sensors for a robot that will help senior citizens remain healthy and safe while living alone, according to Business Insider.

Advertisement

The sensors IBM is developing can perceive changes in motion, audio and scent. Once fully developed, the sensors will go inside the IBM Multi-Purpose Eldercare Robot Assistant (IBM MERA), which IBM has been testing at its Austin-based “Aging in Place” lab. In addition to detecting when a senior citizen has fallen down, the MERA robot has Watson-powered speech recognition and a camera that reads facial expressions.

MERA isn’t available to the general public yet. “In the near-term, it would be more of the ambient sensors in the home starting to gather all of this data,” said Susann Keohane, a senior technologist at IBM Research.

When it does become commercially available, Ms. Keohane expects it will first be marketed in a country such as Japan, where aging among the general populous has become a national concern.

More articles on health IT:
Trump elevates role of top cybersecurity adviser
New Hampshire psychiatric patient accused of breach affecting 15k
16 most popular health IT lists of 2016 

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Register to Attend Webinar

The hidden cost of lost clinical time and how leading health systems are responding

Friday, August 7
12:00 PM - 1:00 PM CDT

Presenters: Kassaundra McKnight-Young, Zebra TechnologiesGregory Carras, Zebra TechnologiesJennifer Gene, Levata

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.